SEC Form 4 · accession 0001127602-18-015935
Encompass Health Corp · EHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark J Tarr
Officer — President & CEO · Director
Period of report
May 1, 2018
Accepted (ET)
May 2, 2018 · 3:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000785161
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Encompass Health Common Stock | May 1, 2018 | M | 33,100 | $7.85 | A | 325,063 | D | |
| Encompass Health Common StockF1 | May 1, 2018 | S | 16,525 | $60.60 | D | 308,538 | D | |
| Encompass Health Common StockF2 | May 1, 2018 | S | 16,575 | $61.32 | D | 291,963 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) | $7.85 | May 1, 2018 | M | 33,100 | D | Feb 27, 2010 | Feb 27, 2019 | Encompass Health Common Stock | 33,100 | 0 | D |
Explanation of responses
- F1This sale price per share is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.995, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (2) below.
- F2This sale price per share is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.575, inclusive.